Lineage-specific overexpression of the P2Y1 receptor induces platelet hyper-reactivity in transgenic mice

被引:49
作者
Hechler, B
Zhang, Y
Eckly, A
Cazenave, JP
Gachet, C
Ravid, K
机构
[1] Boston Univ, Sch Med, Dept Biochem, Whitaker Cardiovasc Inst, Boston, MA 02118 USA
[2] INSERM, U311, Estab Francais Sang Alsace, Strasbourg, France
关键词
adenosine 5 '-diphosphate; hemostasis; P2; receptors; secretion; thrombosis;
D O I
10.1046/j.1538-7836.2003.00003.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In order to investigate the role of the platelet P2Y(1) receptor in several aspects of platelet activation and thrombosis, transgenic (TG) mice overexpressing this receptor specifically in the megakaryocytic/platelet lineage were generated using the promoter of the tissue-specific platelet factor 4 gene. Studies of the saturation binding of [P-33]2MeSADP in the presence or absence of the selective P2Y(1) antagonist MRS2179 indicated that wild-type (WT) mouse platelets bore 150 +/- 31 P2Y(1) receptors and TG platelets 276 +/- 34, representing an 84% increase in P2Y(1) receptor density. This led to a well defined phenotype of platelet hyper-reactivity in vitro, as shown by increased aggregations in response to adenosine 5-diphosphate (ADP) and low concentration of collagen in TG as compared with WT platelets. Moreover, overexpression of the P2Y(1) receptor enabled ADP to induce granule secretion, unlike in WT platelets, which suggests that the level of P2Y(1) expression is critical for this event. Our results further suggest that the weak responses of normal platelets to ADP are due to a limited number of P2Y(1) receptors rather than to activation of a specific transduction pathway. TG mice displayed a shortened bleeding time and an increased sensitivity to in vivo platelet aggregation induced by infusion of a mixture of collagen and epinephrine. Overall, these findings emphasize the importance of the P2Y(1) receptor in hemostasis and thrombosis and suggest that variable expression levels of this receptor on platelets might play a role in thrombotic states in human, which remains to be assessed.
引用
收藏
页码:155 / 163
页数:9
相关论文
共 39 条
  • [1] Inhibition of platelet function by administration of MRS2179, a P2Y1 receptor antagonist
    Baurand, A
    Raboisson, P
    Freund, M
    Léon, C
    Cazenave, JP
    Bourguignon, JJ
    Gachet, C
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2001, 412 (03) : 213 - 221
  • [2] Competitive and selective antagonism of P2Y1 receptors by N6-methyl 2′-deoxyadenosine 3′,5′-bisphosphate
    Boyer, JL
    Mohanram, A
    Camaioni, E
    Jacobson, KA
    Harden, TK
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1998, 124 (01) : 1 - 3
  • [3] BRASS LF, 1992, J BIOL CHEM, V267, P13795
  • [4] Cattaneo M, 1997, THROMB HAEMOSTASIS, V77, P986
  • [5] CATTANEO M, 1992, BLOOD, V80, P2787
  • [6] Platelets from a patient heterozygous for the defect of P2CYC receptors for ADP have a secretion defect despite normal thromboxane A2 production and normal granule stores -: Further evidence that some cases of platelet 'primary secretion defect' are heterozygous for a defect of P2CYC receptors
    Cattaneo, M
    Lecchi, A
    Lombardi, R
    Gachet, C
    Zighetti, ML
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2000, 20 (11) : E101 - E106
  • [7] CAZENAVE JP, 1983, ANN BIOL CLIN-PARIS, V41, P167
  • [8] Molecular basis for ADP-induced platelet activation I. Evidence for three distinct ADP receptors on human platelets
    Daniel, JL
    Dangelmaier, C
    Jin, JG
    Ashby, B
    Smith, JB
    Kunapuli, SP
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (04) : 2024 - 2029
  • [9] DIMINNO G, 1983, J PHARMACOL EXP THER, V225, P57
  • [10] Decreased platelet aggregation, increased bleeding time and resistance to thromboembolism in P2Y1-deficient mice
    Fabre, JE
    Nguyen, MT
    Latour, A
    Keifer, JA
    Audoly, LP
    Coffman, TM
    Koller, BH
    [J]. NATURE MEDICINE, 1999, 5 (10) : 1199 - 1202